178 related articles for article (PubMed ID: 1920135)
1. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
Dedeoğlu A; Fisher LA
J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059
[TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
5. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
6. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Aulakh CS; Hill JL; Yoney HT; Murphy DL
Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
[TBL] [Abstract][Full Text] [Related]
7. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and renin responses to (+-)-DOI, a selective 5-HT2 receptor agonist, in conscious rats.
Alper RH
Eur J Pharmacol; 1990 Jan; 175(3):323-32. PubMed ID: 2182326
[TBL] [Abstract][Full Text] [Related]
9. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
Baudrie V; Chaouloff F
Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656
[TBL] [Abstract][Full Text] [Related]
11. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
12. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
Pranzatelli MR
Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
[TBL] [Abstract][Full Text] [Related]
13. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat.
Alper RH
Neuroendocrinology; 1990 Mar; 51(3):255-60. PubMed ID: 2109269
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
15. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
Anderson IK; Martin GR; Ramage AG
Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
[TBL] [Abstract][Full Text] [Related]
16. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
18. Can the 5-HT2/1c agonist DOI cause differential sympatho-excitation in nerves supplying the heart in anaesthetized cats?
Ramage AG; Shepheard SL; Jordan D; Koss MC
J Auton Nerv Syst; 1993 Jan; 42(1):53-62. PubMed ID: 8436806
[TBL] [Abstract][Full Text] [Related]
19. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
Sheldon PW; Aghajanian GK
Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
[TBL] [Abstract][Full Text] [Related]
20. Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation.
Anderson IK; Martin GR; Ramage AG
Br J Pharmacol; 1995 Sep; 116(2):1751-6. PubMed ID: 8528555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]